Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1972 1
1973 1
1974 2
1975 2
1976 1
1977 2
1979 3
1980 7
1981 8
1982 13
1983 7
1984 4
1985 3
1986 6
1987 2
1988 1
1989 6
1990 4
1991 4
1992 5
1993 6
1994 6
1995 5
1996 2
1997 7
1998 6
1999 2
2000 3
2001 2
2002 5
2003 3
2004 6
2005 3
2006 2
2008 3
2009 3
2010 2
2011 4
2012 3
2014 6
2016 1
2018 1
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
T-bodies as antiviral agents.
Bitton N, Debre P, Eshhar Z, Gorochov G. Bitton N, et al. Among authors: eshhar z. Curr Top Microbiol Immunol. 2001;260:271-300. doi: 10.1007/978-3-662-05783-4_14. Curr Top Microbiol Immunol. 2001. PMID: 11443878 Review. No abstract available.
The emergence of T-bodies/CAR T cells.
Eshhar Z, Waks T, Gross G. Eshhar Z, et al. Cancer J. 2014 Mar-Apr;20(2):123-6. doi: 10.1097/PPO.0000000000000027. Cancer J. 2014. PMID: 24667957 Review.
CAR T cells: Building on the CD19 paradigm.
Globerson Levin A, Rivière I, Eshhar Z, Sadelain M. Globerson Levin A, et al. Among authors: eshhar z. Eur J Immunol. 2021 Sep;51(9):2151-2163. doi: 10.1002/eji.202049064. Epub 2021 Aug 2. Eur J Immunol. 2021. PMID: 34196410 Review.
Catalytic antibodies: a critical assessment.
Tawfik DS, Eshhar Z, Green BS. Tawfik DS, et al. Among authors: eshhar z. Mol Biotechnol. 1994 Feb;1(1):87-103. doi: 10.1007/BF02821512. Mol Biotechnol. 1994. PMID: 7859154 Review.
Tumor-specific allogeneic cells for cancer therapy.
Marcus A, Eshhar Z. Marcus A, et al. Among authors: eshhar z. Expert Opin Biol Ther. 2011 Dec;11(12):1551-4. doi: 10.1517/14712598.2011.628934. Epub 2011 Oct 14. Expert Opin Biol Ther. 2011. PMID: 21995504
169 results